Track topics on Twitter Track topics that are important to you
Lorus Therapeutics Inc. is a pharmaceutical company focused on the development of cancer therapies. Lorus' goal is to capitalize on its pre-clinical, clinical and regulatory expertise by developing new drug candidates that can be used, either alone, or in combination, to successfully manage cancer.
The Company is currently developing a number of novel anti-cancer compounds called NuChem Analogues, based on a commonly used anti-fungal agent, clotrimazole. This technology includes the anti-cancer applications of clotrimazole itself. Clotrimazole has been shown to have unique anti-proliferative activities against cancer cells, including the inhibition of key steps in tumour growth and angiogenesis (new blood vessel formation). Preclinical investigation of a number of these compounds in different tumour models is currently underway.
Virulizin®, a sterile liquid drug formulation for injection, is also being developed. Virulizin® is a new drug with novel biological response modifier activities. It has been shown to stimulate normal peripheral blood monocytes to express cytocidal activity in a dose-dependent manner. North American clinical investigations have focused on advanced pancreatic cancer, malignant melanoma, invasive cervicaluterine carcinoma and HIV-related Kaposi's sarcoma.
Lorus Therapeutics' objective is to maximize the therapeutic value and potential commercial success of its technology. The Company intends to pursue specific developmental, manufacturing, marketing and distribution arrangements with one or more strategic pharmaceutical partners. No such arrangements have been finalized, but the Company is in late-stage discussions with potential strategic partners.
To expand its product pipeline, Lorus Therapeutics is currently reviewing in-licensing opportunities involving new products and technologies in the areas of oncology. Lorus is focusing its efforts on developing therapies with different targets to provide tools for the management of the disease. By treating patients using drugs from several different therapeutic areas, using each drug alone or in combination, the chances of successfully managing cancer can be increased significantly. Lorus is currently developing cytostatic and immunotherapy drug candidates and will continue to look for products in different areas.
2 Meridian Road
Innate immunity-focused IFM Therapeutics is spinning off its non-oncology assets into the new company IFM Therapeutics LLC.
Nabriva Therapeutics plans to raise $80m through an underwritten public offering of shares of its common stock.
ProQR Therapeutics has spun out Amylon Therapeutics, a privately-held company focused on the development of therapies for central nervous system (CNS) disorders, with seed funding from a group of inst...
http://dailystocktracker.com/register/ Cytori Therapeutics San Diego, Californiaheadquartered Cytori Therapeutics Inc.'s shares dropped 2.15%, closing Monday's trading session at $0.39. The stock ...
Tuesday, June 27th 2017 at 11:00am UTC — Company Expands Executive Leadership Team with Key Appointments in Early 2017 — CAMBRIDGE, Mass.–(BUSINESS WIRE)– RaNA Therapeutics tod...
21 - 22 February 2018, London, UK. As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towar...
CAMBRIDGE, Mass. and BASEL, Switzerland, July 10, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines...
MALVERN, PA -- (Marketwired) -- 10/16/17 -- Realm Therapeutics PLC (AIM: RLM) (AIM: RLM) Realm Therapeutics plc ("Realm Therapeutics", "Realm" or the "Company") Realm Therapeutics to Present at th...
ALDEX GS™ Tablets
ALDEX GS DMTablets
The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...
Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System
The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...
The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...
This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...
Lorus Therapeutics Inc. is a pharmaceutical company focused on the development of cancer therapies. Lorus' goal is to capitalize on its pre-clinical, clinical and regulatory expertise by developing ne...
Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...
Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...
Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...
We have published hundreds of Lorus Therapeutics news stories on BioPortfolio along with dozens of Lorus Therapeutics Clinical Trials and PubMed Articles about Lorus Therapeutics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lorus Therapeutics Companies in our database. You can also find out about relevant Lorus Therapeutics Drugs and Medications on this site too.
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...